Division of Hematology and Transfusion Medicine
271 – 280 of 802
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
The ins and outs of SMIM1 and its relationship to the expression of Vel blood group antigen
2017) 27th Regional Congress of the International Society of Blood Transfusion, ISBT 2017 In Vox Sanguinis 112(Suppl. 1). p.48-49(
- Contribution to journal › Published meeting abstract
-
Mark
T regulatory cells and dendritic cells protect against transfusion-related acute lung injury via IL-10
(
- Contribution to journal › Article
-
Mark
Mature murine megakaryocytes present antigen-MHC class I molecules to T cells and transfer them to platelets
(
- Contribution to journal › Article
-
Mark
Erythroid Culture Based on Differentiation of Progenitor Cells from Leftover Buffy Coats Produced in the Reveos Automated Blood Processing System
2017) 27th Regional Congress of the International Society of Blood Transfusion, ISBT 2017 In Vox Sanguinis 112(supp 1). p.288-288(
- Contribution to journal › Published meeting abstract
-
Mark
Working toward precision medicine : Predicting phenotypes from exomes in the Critical Assessment of Genome Interpretation (CAGI) challenges
(
- Contribution to journal › Article
-
Mark
Prevention of alloimmunization during pregnancy by prednisone and immunoglobulin G-What is the evidence?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Incidence and outcome of acquired aplastic anemia : Real-world data from patients diagnosed in Sweden from 2000–2011
(
- Contribution to journal › Article
-
Mark
Bioinformatic approaches to gene expression in leukemia. Networks and deconvolution
2017)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Linear decline of corrected platelet count increment within 24 hours after platelet transfusion in haematological patients : a prospective observational study
(
- Contribution to journal › Article
-
Mark
Adverse event management in patients with relapsed and refractory multiple myeloma taking pomalidomide plus low-dose dexamethasone : A pooled analysis
(
- Contribution to journal › Article